Hebei Jiudian Pharmaceutical Chemical Co., Ltd. announced that it expects to receive CNY 40 million in funding from Hebei Jianxin Chemical Co., Ltd.
September 25, 2019
Share
Hebei Jiudian Pharmaceutical Chemical Co., Ltd. announced that it has entered into capital increase agreement to receive CNY 40,000,000 from new investor Hebei Jianxin Chemical Co., Ltd. (SZSE:300107) on September 25, 2019. Post to the transaction, the registered capital of the company will increase from CNY 30,000,000 to CNY 70,000,000. The transaction has been approved in the 19th meeting of the 4th directorate of the investor.
Hebei Jianxin Chemical Co Ltd is a China-based company mainly engaged in the production and sales of benzene-based intermediate products. The Company's main product lines can be divided into composite material intermediates, pharmaceutical and pesticide intermediates, dye intermediates and paper chemicals. The Company's main products include m-aminobenzenesulfonic acid, aniline-2,5-disulfonic acid monosodium salt, m-hydroxy-N, N-diethylaniline, m-aminophenol, ODB-2, Jianxin201, 4,4'-Diaminodiphenyl sulfone, 4,4'-dichlorodiphenyl sulfone, 3,3'-diaminodiphenyl sulfone, among others. The Company's products are mainly used in medicine, composite materials, dyes, papermaking and other fields. The Company's products are distributed to domestic and overseas markets.
HEBEI JIANXIN CHEMICAL CO., LTD. 
